Tiziana Life Sciences Ltd (TLSA) DCF Valuation

Tiziana Life Sciences Ltd (TLSA) Valation DCF

GB | Healthcare | Biotechnology | NASDAQ
Tiziana Life Sciences Ltd (TLSA) DCF Valuation

Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets

Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur

Pré-Construits Pour Une Utilisation Rapide Et Efficace

Compatible MAC/PC, entièrement débloqué

Aucune Expertise N'Est Requise; Facile À Suivre

Tiziana Life Sciences Ltd (TLSA) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explorez les perspectives financières de Tiziana Life Sciences Ltd (TLSA) avec notre calculatrice DCF conviviale! Entrez vos hypothèses concernant la croissance, les marges et les dépenses pour calculer la valeur intrinsèque de Tiziana Life Sciences Ltd (TLSA) et affiner votre approche d'investissement.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -10.3 -37.9 -35.7 -20.8 -23.2 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .3 .1 .2 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -10.5 -38.0 -35.9 -20.9 -23.4 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .2 89.2 57.2 24.6 1.6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 5.1 7.1 7.9 8.2
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 4.3 4.6 6.0 6.7 5.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % -2.6 -2.6 -2.6 -2.6 -2.6 -2.6 -2.6 -2.6 -2.6 -2.6
EBITAT -9.8 -35.0 -31.5 -20.9 -24.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.2 -39.8 -32.0 -20.8 -25.2 2.6 .0 .0 .0 .0
WACC, % 4.87 4.87 4.87 4.87 4.87 4.87 4.87 4.87 4.87 4.87
PV UFCF
SUM PV UFCF 2.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 2
Net Debt -1
Equity Value 4
Diluted Shares Outstanding, MM 25
Equity Value Per Share 0.15

What You Will Get

  • Real Tiziana Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Tiziana Life Sciences Ltd (TLSA).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to Tiziana Life Sciences Ltd (TLSA).
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Tiziana Life Sciences Ltd (TLSA)'s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for Tiziana Life Sciences Ltd (TLSA).
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Tiziana Life Sciences Ltd (TLSA).

Key Features

  • Customizable Research Parameters: Adjust essential inputs such as clinical trial timelines, market potential, and R&D expenditures.
  • Instant Valuation Metrics: Quickly computes intrinsic value, NPV, and additional financial outputs.
  • High-Precision Estimates: Utilizes Tiziana Life Sciences Ltd's (TLSA) actual financial data for accurate valuation results.
  • Effortless Scenario Testing: Evaluate various assumptions and analyze results with ease.
  • Efficiency Booster: Remove the hassle of creating intricate valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file for Tiziana Life Sciences Ltd (TLSA).
  2. Step 2: Review the pre-filled financial data and forecasts for Tiziana Life Sciences Ltd (TLSA).
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells) for Tiziana Life Sciences Ltd (TLSA).
  4. Step 4: Observe the DCF model update in real-time as you modify your assumptions for Tiziana Life Sciences Ltd (TLSA).
  5. Step 5: Evaluate the outputs and leverage the results for your investment strategies regarding Tiziana Life Sciences Ltd (TLSA).

Why Choose This Calculator for Tiziana Life Sciences Ltd (TLSA)?

  • User-Friendly Interface: Perfect for both novice users and seasoned professionals.
  • Customizable Inputs: Adjust parameters easily to suit your investment analysis.
  • Real-Time Valuation: Observe immediate updates to Tiziana's valuation as you make changes.
  • Preloaded Financials: Comes equipped with Tiziana’s latest financial data for efficient assessments.
  • Relied Upon by Experts: Utilized by analysts and investors for strategic decision-making.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessment of Tiziana Life Sciences Ltd (TLSA).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
  • Consultants and Advisors: Deliver precise valuation insights to clients regarding Tiziana Life Sciences Ltd (TLSA).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech companies like Tiziana Life Sciences Ltd (TLSA) are valued in the market.

What the Template Contains

  • Preloaded TLSA Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

No products were found matching.